Academic Area
Molecular Medicine & Biomedical Sciences
Advance Materials and Devices
Material Science
Basic Life Sciences
Teaching Interests
Stem Cell Biology
Tissue Engineering
Qualifications
Graduation : B.Sc(Chemistry, Botany & Zoology)-1996,R.T.E.S. College Ranebennur
Post Graduation : M.Sc(Zoology)-1998,Karnataka University
Post Graduation : M.Phil(Zoology)-2000,Karnataka University
Doctorate : Ph.D.(Reproductive Biology)-2002,Karnataka University
Experience
20 Jul 2015 - Present
Professor,
Amity Institute of Molecular Medicine & Stem Cell Research
13 May 2011 - 18 Jul 2015
Research Associate,
National Institute of Immunology,
Delhi
05 Jul 2007 - 11 May 2011
Scientist,
Excel Matrics Biological Divice Pvt. Ltd.,
Hyderabad
Current Courses Taught
Anatomy,Physiology and Basic Embryology
Clinical Study & Research (case study/ log book)
Dissertation
Infertility Management and Assisted Reproductive Techniques
Quality Control, Medico Legal, Regulatory and Ethical Aspects
Research Interests
Stem Cell Therapy
Tissue Engineering
Development of Biomaterials
Organ Development
Publications
Molecular and cellular functions distinguish superior therapeutic efficiency of bone marrow CD45 cells over mesenchymal stem cells in liver cirrhosis. ,
Stem cells
Nonmulberry Silk Fibroin Scaffold Shows Superior Osteoconductivity Than Mulberry Silk Fibroin in Calvarial Bone Regeneration ,
WILEY-VCH Verlag GmbH & Co. KGaA, Weinheim
Donor antigen-primed regulatory T cells permit liver regeneration and phenotype correction in hemophilia A mouse by allogeneic bone marrow stem cells ,
BioMed Central
Bone marrow stem-cell therapy for genetic and chronic liver diseases. ,
Springer
Therapeutics Potential of bone marrow-derived stem cells in treatment of genetic diseases of liver. ,
Springer
Molecular and Cellular Functions Distinguish Superior Therapeutic Efficiency of Bone Marrow CD45 Cells Over Mesenchymal Stem Cells in Liver Cirrhosis ,
Stem cells
Bone Marrow Cells Repair and Regenerate Acute and Chronic Injured Liver without Primary Evidence of Neoplastic Changes ,
International Journal of Stem Cell Research & Therapy
Experimental Liver Fibrosis and Intrasplenic Transplantation of CD45 + Bone Marrow Cells ,
Bio-Protocol
Role of antigen presenting cell invariant chain in the development of hepatic steatosis in mouse model ,
Elsevier-Experimental Cell Research
Bone Marrow Stem Cell Therapy Partially Ameliorates Pathological Consequences in Livers of Mice Expressing Mutant Human a1-Antitrypsin ,
HEPATOLOGY -Wiley Blackwell
Projects
Ex vivo partial liver organ development by using stem cells and tissue engineering approaches(xxxxx)
The liver
transplantation is the primary option for patients with acute liver failure or end-stage liver diseases. In spite of surgical advancement, this
approach has certain draw backs like limited availability of the donor liver and use of
immunosuppressive drugs lifelong. However, till date there is no 3D liver ex vivo model for treating
many liver diseases and testing of drugs during the clinical development. Therefore, alternative strategies for the treatment of liver diseases are veryby (DST-SERB)
Ex vivo partial liver organ development by using stem cells and tissue engineering approaches(xxxxxx)
The liver
transplantation is the primary option for patients with acute liver failure or end-stage liver diseases.
Various surgical options have been followed to increase the supply of liver including split liver
transplants and living-related partial donor procedures. In spite of surgical advancement, this
approach has certain draw backs like limited availability of the donor liver and use of
immunosuppressive drugs lifelong. However, till date there is no 3D liver ex vivo model for treatby (DST-SERB)
Short Description
I did MSc, PhD. from Karnatak university Dharwad, Karnataka. I have about 10 years of research experience in the field of Stem cells and tissue engineering and 3yeras of teaching experience for the PG student of Biotechnology. I have published 18 publications in the peer reviewed journals, 2 chapters in the Book and 1 US patent in the stem cell therapy. Presently, joined as a asst Prof in Amity university on 20 July 2015 and submitted a project proposal to DST-SERB early carrier research grant award on 28 Sept 2015. And I am teaching for the MSc course of AIMMSCR.